{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:01Z","timestamp":1786119601901,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/wnf.0b013e3181f8d501","type":"journal-article","created":{"date-parts":[[2010,10,2]],"date-time":"2010-10-02T06:12:13Z","timestamp":1285999933000},"page":"297-302","source":"Crossref","is-referenced-by-count":4,"title":["An Open-Label Tolerability Study of BL-1020 Antipsychotic"],"prefix":"10.1097","volume":"33","author":[{"given":"Ravi","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yona","family":"Geffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Vasile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210203","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/070674370304801107","article-title":"From chlorpromazine to clozapine-antipsychotic adverse effects and the clinician's dilemma.","volume":"48","author":"Abidi","year":"2003","journal-title":"Can J Psychiatry"},{"key":"R2-7-20210203","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis.","volume":"156","author":"Allison","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R3-7-20210203","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.","volume":"321","author":"Geddes","year":"2000","journal-title":"BMJ"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1176\/appi.ajp.160.2.290","article-title":"Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.","volume":"160","author":"Lindenmayer","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/appi.ajp.159.4.561","article-title":"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.","volume":"159","author":"Sernyak","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/jm7012453","article-title":"A mutual prodrug ester of GABA and perphenazine exhibits antischizophrenic efficacy with diminished extrapyramidal effects.","volume":"51","author":"Nudelman","year":"2008","journal-title":"J Med Chem"},{"key":"R8-7-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2008.07.002","article-title":"BL-1020: A novel anti-psychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia.","volume":"19","author":"Geffen","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/cercor\/5.6.550","article-title":"GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls.","volume":"5","author":"Akbarian","year":"1995","journal-title":"Cereb Cortex"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0920-9964(96)00122-3","article-title":"Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics.","volume":"24","author":"Beasley","year":"1997","journal-title":"Schizophr Res"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0165-0173(99)00041-7","article-title":"Emerging principles of altered neural circuitry in schizophrenia.","volume":"31","author":"Benes","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"issue":"Pt 4","key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/brain\/122.4.593","article-title":"The neuropathology of schizophrenia. A critical review of the data and their interpretation.","volume":"122","author":"Harrison","year":"1999","journal-title":"Brain"},{"key":"R13-7-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0304-3940(89)90819-7","article-title":"Reduced GABA uptake sites in the temporal lobe in schizophrenia.","volume":"107","author":"Simpson","year":"1989","journal-title":"Neurosci Lett"},{"key":"R14-7-20210203","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.jcp.0000095349.32154.a5","article-title":"GABA and schizophrenia: a review of basic science and clinical studies.","volume":"23","author":"Wassef","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R15-7-20210203","first-page":"217","article-title":"The neuropathology of GABA neurons in extrapyramidal disorders.","volume":"16","author":"Lloyd","year":"1980","journal-title":"J Neural Transm"},{"key":"R16-7-20210203","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-005-2212-8","article-title":"GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.","volume":"180","author":"Guidotti","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R17-7-20210203","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.euroneuro.2009.07.009","article-title":"BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humans.","volume":"19","author":"Appel","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"R18-7-20210203","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"R21-7-20210203","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.schres.2005.06.021","article-title":"Psychometric evaluation of the Readiness for Discharge Questionnaire.","volume":"80","author":"Potkin","year":"2005","journal-title":"Schizophr Res"},{"key":"R22-7-20210203","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2005.02.013","article-title":"Manual for the Extrapyramidal Symptom Rating Scale (ESRS).","volume":"76","author":"Chouinard","year":"2005","journal-title":"Schizophr Res"},{"key":"R23-7-20210203","first-page":"233","article-title":"Extrapyramidal symptom rating scale.","volume":"7","author":"Chouinard","year":"1980","journal-title":"Can J Neurol Sci"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNF.0b013e3181f8d501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:42:06Z","timestamp":1786041726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201011000-00007"}},"subtitle":["A Novel Gamma Aminobutyric Acid Ester of Perphenazine"],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181f8d501","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}